Optimizing next-generation RSV prevention in Mali: A cost-effectiveness analysis of pediatric vaccination, maternal vaccination, and extended half-life monoclonal antibody immunoprophylaxis.

• Ngā kaituhi matua: Rachel S Laufer (Author), Ranju Baral (Author), Andrea G Buchwald (Author), James D Campbell (Author), Flanon Coulibaly (Author), Fatoumata Diallo (Author), Moussa Doumbia (Author), Amanda J Driscoll (Author), Alison P Galvani (Author), Adama M Keita (Author), Kathleen M Neuzil (Author), Samba Sow (Author), Clint Pecenka (Author), Justin R Ortiz (Author), Meagan C Fitzpatrick (Author)
• Hōputu: Pukapuka
• I whakaputaina: Public Library of Science (PLoS), 2023-01-01T00:00:00Z.
• Ngā marau: article
• Urunga tuihono: Connect to this object online.

Respiratory syncytial virus (RSV) is the most common cause of early childhood lower respiratory tract infection (LRTI) in low- and middle-income countries (LMICs). Maternal vaccines, birth-dose extended half-life monoclonal antibodies (mAbs), and pediatric vaccines are under development for preventi...